Coronavirus vaccine developers have pledged their commitment to diversity in clinical trials. "Ensuring diversity in these trials, including in terms of race, ethnicity, gender, age, and other factors, is a priority in our efforts," said Menelas Pangalos, AstraZeneca Plc's executive vice president of biopharmaceutical research & development. With an extensive global network and a direct-to-patient service offering, Yourway can bring trial supplies around the world in hours, not days.